Evidence map›Paper›PMID 26212898›Full record

ArticleBiological psychiatry2016

The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models.

Sachin Patel, Brian C Shonesy, Rebecca J Bluett, Danny G Winder, Roger J Colbran

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping.International journal of molecular sciences · 2020
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sachin PatelDepartments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee; Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee. Electronic address: sachin.patel@vanderbilt.edu.
Brian C ShonesyMolecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Rebecca J BluettDepartments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee.
Danny G WinderDepartments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee; Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee.
Roger J ColbranMolecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee.
Vanderbilt Health · USVanderbilt University · USJohn F. Kennedy Center for the Performing Arts · US

Funding

Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
CaMKII, endocannabinoids, synaptic plasticity and motor functionR01NS078291 · NINDS · VANDERBILT UNIVERSITY · PI COLBRAN, ROGER J · 2012 to 2016
$1.8M
Stress adaptations in endocannabinoid signaling in the amygdalaK08MH090412 · NIMH · VANDERBILT UNIVERSITY · PI PATEL, SACHIN · 2010 to 2014
$842k
Endocannabinoids in social and repetitive behavioral domainsK01MH107765 · NIMH · VANDERBILT UNIVERSITY · PI SHONESY, BRIAN C · 2015 to 2018
$454k
NIMH NIH HHS K01 MH107765NIMH NIH HHS K08 MH090412NIMH NIH HHS T32 MH065215NINDS NIH HHS R01 NS078291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Anxiety AgentsEndocannabinoidsArachidonic AcidsGlyceridesHumansAnti-Anxiety AgentsArachidonic AcidsEndocannabinoidsGlyceridesglyceryl 2-arachidonate

Identifiers

PMID26212898
OpenAlexW1040661821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.